|

Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank

RECRUITINGSponsored by Gustave Roussy, Cancer Campus, Grand Paris
Actively Recruiting
SponsorGustave Roussy, Cancer Campus, Grand Paris
Started2013-07-23
Est. completion2036-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02666625

Summary

The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients treated for a first cancer in childhood
* Adult patients
* Signed informed consent
* Patient insured or enjoying a social security scheme

Exclusion Criteria:

* Minor patients
* Under legal protection measure patients
* Refusal of consent

Conditions2

CancerPaediatric Malignancies

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.